Melanoma Surveillance Photography (MSP) to Improve Early Detection of Melanoma in Ultra-high and High Risk Patients

Prior treatment

• Previously under active surveillance with TBP (active surveillance referring to TBP images being used for melanoma surveillance Stage IV metastatic melanoma

Other illness

• Participation in another clinical trial or study involving MSP
  • Note:
  • A past history of other cancers is not an exclusion criteria.
  • \*These eligibility criteria cannot be assessed by the cancer registry. These criteria will be assessed by the study team and/or referring doctor.

Other

• Patients will be excluded from the study for ANY of the following reasons:
• Stage IV metastatic melanoma
• Ocular melanoma, mucosal melanoma

• Patients may be included in the study if they meet ALL of the following criteria:
• Aged 18 years or older at date of diagnosis
• Within 24 months (2 years) of the date of diagnosis when attending Screening \& Baseline Visit: where date of diagnosis refers to the date on the pathology report that provides histological confirmation of primary cutaneous melanoma (insitu or invasive)
• Able to provide informed consent, complete questionnaires, and attend trial site for MSP\*
• Appropriate for TBP referral
• High/very high risk of subsequent primary melanoma (see risk assessment tool, Appendix IV)\*
• Multiple naevi, as "some" or "many" naevi on pictogram below at Screening \& Baseline visit.
• Not previously under active surveillance (at least yearly) with TBP for melanoma surveillance (see inclusion criteria 9)
• Living in Australia and not planning to move overseas within the next 3 years
• Participants that meet all eligibility criteria but have previously been under active surveillance with TBP for at least the previous 2 years meet exclusion critierion 1, in which case they are ineligible for the main study and eligible for sub-study 1 only.
  • Active surveillance with TBP refers to TBP images having been taken AND used for melanoma surveillance. As such, if a patient had TBP but these images were not used for melanoma surveillance (i.e. not used by clinicians to monitor a patient's skin), then surveillance is not considered active and the patient would still be eligible for the main study (as well as sub-study 1).
• Patients need to have had at least annual surveillance over the past 2 years (at least) to be eligible for sub-study 1 (note that this refers to annual skin surveillance not annual TBP images being taken) (i.e. do not meet inclusion criteria 7 are eligible for sub-study 1)